Anti-Factor Xa Test results in <15 minutes directly from 50 µL whole blood Heparin dosing requires tight and timely control to prevent both bleeding and clotting complications. Anti-Factor Xa tests are confined to central labs and often take over an hour, delaying time-sensitive dosing. Designed for patients receiving unfractionated or low molecular weight heparin, the FINDER® Anti-Factor Xa Test delivers results in <15 minutes from just a 50 µL drop of whole blood. By enabling heparin monitoring at the point of care, FINDER helps clinicians optimize dosing quickly and effectively in critical care settings. Baebies Early Access Program offers select clinical partners an opportunity to evaluate the FINDER Anti-Factor Xa Test. Join a growing list of top hospitals shaping the future of point-of-care testing. No Centrifugation Needed Anti-Factor Xa test results directly from 50 µL of whole blood Ultra-rapid Results Delivers positive results in <15 minutes right at the point-of-care Intuitive 3-Step Workflow No specialized training required and minimal hands-on time Novel Fluorogenic Substrate Overcome chromogenic substrate’s spectral interference with bilirubin and hemoglobin Hybrid Calibration Engineered to measure both Unfractionated Heparin and Low Molecular Weight Heparin Built-In Quality Controls Over 100 integrity checkpoints on-cartridge to ensure reliable results Read Further:
Any test. Anywhere. Everyone.™
FDA Breakthrough Designation for First Point-of-Care Heparin Monitoring Test
FINDER Utilizes Digital Microfluidics to Deliver:
Intuitive Workflow in 4 Simple Steps
Info@baebies.com
Call us: +1 (919) 891-0432
